In a research report issued today, MLV analyst George Zavoico reiterated a Buy rating on Cerus Corp. (NASDAQ:CERS) with a $7 price target, as the company announced …
In a research note released today, MLV analyst George Zavoico reiterated a Buy rating on Cerus Corp. (NASDAQ:CERS) and raised his price target …
In a research report published today, MLV analyst George Zavoico maintained a Buy rating on Aeterna Zentaris (NASDAQ:AEZS) but reduced his price target …
MLV analyst George Zavoico is out today with his second report this week on Oxigene (NASDAQ:OXGN), maintaining a Buy rating with a $6.50 price target, as Genentech …
In a research report issued today, MLV analyst George Zavoico maintained a Buy rating on Geron (NASDAQ:GERN) with a price target of $4.25, …
In a research report released Wednesday, MLV analyst George Zavoico reiterated a Buy rating on Peregrine Pharma (NASDAQ:PPHM) with a $3.50 price target, following presentation …
After initiating coverage last week, MLV analyst George Zavoico is out today with his second report on Oxigene (NASDAQ:OXGN), maintaining a Buy rating with a $6.50 …
In a research report sent to investors, MLV analyst George Zavoico initiated Buy rating on Oxigene (NASDAQ:OXGN) with a $6.50 price target, which …
In a research report released yesterday, MLV analyst George Zavoico upgrades shares of Cytokinetics (NASDAQ:CYTK) from a Hold to a Buy rating and increased his …
In a research note issued today, MLV analyst George Zavoico maintained a Buy rating on Geron (NASDAQ:GERN) with a $4.25 price target, following the …
